Lefamulin Acetate — Active Pharmaceutical Ingredient

Lefamulin Acetate is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: TABLET, SOLUTION. Routes: ORAL, INTRAVENOUS.

This content is for informational purposes only. Always consult a healthcare professional.

Lefamulin Acetate (1 brand name, 2 dosage forms, 2 routes)

Available dosage forms: TABLET, SOLUTION.

Routes of administration: ORAL, INTRAVENOUS.

Brand Names

  • XENLETA

Adverse Reactions

The following clinically significant adverse reactions are described elsewhere in the labeling: QT Prolongation [see Warnings and Precautions (5.1)]. Clostridioides difficile-associated Diarrhea [see Warnings and Precautions (5.3)].

Mechanism of Action

XENLETA is an antibacterial drug [see Microbiology (12.4)].

Overdosage

Treatment of overdose with XENLETA should consist of observation and general support measures. Lefamulin and its primary metabolite are not dialyzable.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.